上睑下垂
脊髓损伤
神经炎症
基因剔除小鼠
MMP9公司
细胞生物学
小胶质细胞
体内
炎症体
NF-κB
化学
脊髓
下调和上调
医学
生物
神经科学
免疫学
炎症
信号转导
基因
生物化学
生物技术
作者
Dachuan Li,Siyang Liu,Xiao Lu,Zhaoyang Gong,Hongli Wang,Xinlei Xia,Feizhou Lu,Jianyuan Jiang,Yuxuan Zhang,Guangyu Xu,Fei Zou,Xiaosheng Ma
摘要
BACKGROUND: The treatment of spinal cord injury (SCI) is usually ineffective, because neuroinflammatory secondary injury is an important cause of the continuous development of spinal cord injury, and microglial pyroptosis is an important step of neuroinflammation. Recently, Bmal1, a core component of circadian clock genes (CCGs), has been shown to play a regulatory role in various tissues and cells. However, it is still unclear whether Bmal1 regulates microglial pyroptosis after SCI. METHODS: In this study, we established an in vivo mouse model of SCI using Bmal1 knockout (KO) mice and wild-type (WT) mice, and lipopolysaccharide (LPS)-induced pyroptosis in BV2 cells as an in vitro model. A series of molecular and histological methods were used to detect the level of pyroptosis and explore the regulatory mechanism in vivo and in vitro respectively. RESULTS: Both in vitro and in vivo results showed that Bmal1 inhibited NLRP3 inflammasome activation and microglial pyroptosis after SCI. Further analysis showed that Bmal1 inhibited pyroptosis-related proteins (NLRP3, Caspase-1, ASC, GSDMD-N) and reduced the release of IL-18 and IL-1β by inhibiting the NF-κB /MMP9 pathway. It was important that NF-κB was identified as a transcription factor that promotes the expression of MMP9, which in turn regulates microglial pyroptosis after SCI. CONCLUSIONS: Our study initially identified that Bmal1 regulates the NF-κB /MMP9 pathway to reduce microglial pyroptosis and thereby reduce secondary spinal cord injury, providing a new promising therapeutic target for SCI.
科研通智能强力驱动
Strongly Powered by AbleSci AI